Surprisingly, EGFR inhibitors can promote axon regeneration, reduce myelin loss, promote the upregulation of growth-related proteins, and ultimately improve the recovery of limb motor function after spinal cord injury (32). The gene discussed is EGFR; the disease is spinal cord injury.